AgomAb Therapeutics NV American Depositary Shares (AGMB) — Financial Flexibility Index
AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Financial Flexibility Index of -0.65x as of March 2026. Free cash flow of $-12.07 Million (operating CF $-12.44 Million minus capex $363.00K) represents -1% of total liabilities ($18.70 Million). Check AgomAb Therapeutics NV American Deposita tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AgomAb Therapeutics NV American Depositary Shares Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for AgomAb Therapeutics NV American Depositary Shares across 4 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of AgomAb Therapeutics NV American Deposita.
Annual Financial Flexibility Index for AgomAb Therapeutics NV American Depositary Shares (2022–2025)
Year-by-year free cash flow to debt coverage for AgomAb Therapeutics NV American Depositary Shares. Explore debt repayment capacity of AgomAb Therapeutics NV American Deposita to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.27x | $-51.74 Million | $-51.74 Million | $22.80 Million | ▲ +10.2% |
| 2024 | -2.53x | $-46.15 Million | $-46.83 Million | $18.28 Million | ▼ -103.6% |
| 2023 | -1.24x | $-24.59 Million | $-24.59 Million | $19.82 Million | ▼ -127.3% |
| 2022 | -0.55x | $-18.97 Million | $-18.97 Million | $34.75 Million | — |